Kardium har färdigst
Kardium har färdigställt patientrekryteringen inför ansökan om marknadsgodkännande
April 02, 2024 10:41 ET | Corline Biomedical AB
Kardium Inc. – en av Corlines kunder, som använder CHS™-ytan på sin Globe-kateter för behandling av hjärtarytmi – meddelar idag att man färdigställt patientrekryteringen i den registreringsgrundande...
ITGR LOGO (2019-09-25) intgr_ful_r_4cp_hor.png
Integer Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024
March 28, 2024 08:00 ET | Integer Holdings Corporation
PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m....
Neuronetics_logo-RGB purple.png
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
March 25, 2024 08:30 ET | Neuronetics
MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Sequel twiist(TM) Automated Insulin Delivery (AID) system
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
March 18, 2024 07:05 ET | Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
Logo 400x400.jpg
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024 16:39 ET | CytoSorbents
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
logo.png
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
March 14, 2024 08:15 ET | Autonomix Medical, Inc.
First trial to ever evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer THE WOODLANDS, TX, March 14, 2024 (GLOBE NEWSWIRE) --...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
March 13, 2024 16:05 ET | electroCore, Inc.
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY,...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in Upcoming Investor Conferences
March 12, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy...
Neuronetics_logo-RGB purple.png
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
March 07, 2024 08:22 ET | Neuronetics
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Noah_Medical_logo_MASTER.jpg
Noah Medical Named a “Fierce 15” Company of 2023 by Fierce MedTech
March 06, 2024 08:00 ET | Noah Medical
Medical robotics innovator Noah Medical announced today that Fierce MedTech has named it one of 2023’s “Fierce 15” medical technology companies.